By 2030, the global biotech industry is expected to reach a market value of $1,684B.…
The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial,…
Challenging targets, such as membrane proteins or protein-protein interactions were considered undruggable in the past.…
Here’s a list of the public European biotech companies that are worth more than a…
Europe has a number of bubbling biotech hubs that offer access to expertise, financial support,…
Switzerland has long been known as a booming biotech hotspot in Europe that boasts many…
With a tumultuous year behind us, 2021 is set out to spell change for many…
The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs…
Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights…
Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs…
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
Meet the most successful biotech companies in Belgium, a small country that makes a huge…
